Chronic Plaque Psoriasis clinical trials

Explore recruiting chronic plaque psoriasis clinical trials.

Recruiting chronic plaque psoriasis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Plaque Psoriasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, double-blind, randomized, placebo-controlled, parallel-group, twelve-week treatment proof-of-concept trial to explore the efficacy and safety of IDOR-1117-2520 in adults with moderate to severe chronic plaque psoriasis with or without psoriatic arthritis.

Romania, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants (≥6 To <18 Years of Age)

Germany, Hungary, Belgium, Italy, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Placebo and Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety and Pharmacokinetics (PK) of Tildrakizumab in Pediatric Subjects from 6 to <18 Years of Age with Moderate to Severe Chronic Plaque Psoriasis

Hungary, Slovakia, Spain, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

Czechia, Spain, Poland, Bulgaria, Italy, Portugal +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Chronic Plaque Psoriasis trials by city

Chronic Plaque Psoriasis in Toronto Chronic Plaque Psoriasis in Vancouver Chronic Plaque Psoriasis in Montreal Chronic Plaque Psoriasis in Calgary Chronic Plaque Psoriasis in Edmonton Chronic Plaque Psoriasis in Ottawa Chronic Plaque Psoriasis in Winnipeg Chronic Plaque Psoriasis in Quebec City Chronic Plaque Psoriasis in Hamilton Chronic Plaque Psoriasis in Kitchener Chronic Plaque Psoriasis in London Chronic Plaque Psoriasis in Halifax Chronic Plaque Psoriasis in New York Chronic Plaque Psoriasis in Los Angeles Chronic Plaque Psoriasis in Chicago Chronic Plaque Psoriasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease